|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$81,660,525 |
|
|
Indirect Value
|
$12,932,114,466 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,013,774,992 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 55 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
INCY |
Incyte Corp |
Director |
|
2012-01-12 |
4 |
B |
$16.21 |
$5,297,473 |
I/I |
325,728 |
12,213,272 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2007-04-13 |
4 |
S |
$15.30 |
$5,436,414 |
I/I |
(355,122) |
4,141,477 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-16 |
4 |
B |
$28.96 |
$5,499,497 |
I/I |
184,980 |
7,592,527 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-06-09 |
4 |
B |
$4.00 |
$5,794,759 |
I/I |
1,447,207 |
2,962,250 |
2.1 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2010-06-08 |
4 |
B |
$11.92 |
$5,814,557 |
I/I |
486,569 |
11,718,889 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2010-05-10 |
4 |
S |
$12.70 |
$5,881,836 |
I/I |
(463,082) |
2,288,013 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2009-02-06 |
4 |
S |
$8.17 |
$6,148,420 |
I/I |
(752,204) |
5,771,961 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-22 |
4 |
B |
$16.67 |
$6,283,985 |
I/I |
376,975 |
2,822,532 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-05-22 |
4 |
B |
$5.64 |
$6,466,046 |
I/I |
1,146,462 |
8,002,776 |
1.5 |
- |
|
INCY |
Incyte Corp |
Director |
|
2022-02-22 |
4 |
B |
$68.07 |
$6,793,536 |
I/I |
99,800 |
33,039,604 |
2.25 |
% |
|
INCY |
Incyte Corp |
Director |
|
2022-03-08 |
4 |
B |
$70.68 |
$7,067,500 |
I/I |
100,000 |
33,151,989 |
2.25 |
% |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-05-14 |
4 |
B |
$31.53 |
$7,153,896 |
I/I |
212,438 |
239,821 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2009-05-20 |
4 |
B |
$9.72 |
$7,256,670 |
I/I |
746,571 |
8,684,009 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-07 |
4 |
B |
$24.90 |
$7,430,585 |
I/I |
297,340 |
5,601,422 |
2.25 |
- |
|
KOD |
Kodiak Sciences Inc. |
Director |
|
2022-01-21 |
4 |
B |
$56.57 |
$7,577,571 |
I/I |
133,414 |
13,660,140 |
2.25 |
% |
|
INCY |
Incyte Corp |
Director |
|
2008-07-31 |
4 |
B |
$9.00 |
$7,776,828 |
I/I |
864,092 |
6,291,968 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2007-02-14 |
4 |
S |
$8.72 |
$8,718,099 |
I/I |
(999,782) |
1,153,217 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2022-02-18 |
4 |
B |
$68.37 |
$9,096,550 |
I/I |
133,032 |
32,947,370 |
2.25 |
% |
|
INCY |
Incyte Corp |
Director |
|
2010-09-21 |
4 |
S |
$14.94 |
$9,116,306 |
I/I |
(610,072) |
7,917,761 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2009-02-04 |
4 |
S |
$8.01 |
$9,233,914 |
I/I |
(1,106,246) |
6,896,530 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-21 |
4 |
B |
$15.50 |
$10,965,599 |
I/I |
707,458 |
2,445,557 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2010-04-29 |
4 |
B |
$12.98 |
$10,987,554 |
I/I |
844,061 |
2,737,856 |
1.5 |
- |
|
KOD |
Kodiak Sciences Inc. |
Director |
|
2022-01-27 |
4 |
B |
$51.59 |
$13,573,519 |
I/I |
262,259 |
14,285,631 |
2.25 |
% |
|
SGEN |
Seagen Inc |
Director |
|
2007-02-14 |
4 |
S |
$8.72 |
$13,950,186 |
I/I |
(1,599,792) |
3,474,819 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2007-01-29 |
4 |
B |
$6.00 |
$14,045,868 |
I/I |
2,340,978 |
6,828,897 |
1.5 |
- |
|
1397 Records found
|
|
Page 55 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|